Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Luckin Coffee share price may nearly double to $60 on U.S. exchanges: hedge fund Citron Capital

Published 02/04/2020, 01:09 PM
Updated 02/04/2020, 01:11 PM
Luckin Coffee share price may nearly double to $60 on U.S. exchanges: hedge fund Citron Capital
SBUX
-
BHC
-
LKNCY
-

By Saqib Iqbal Ahmed

NEW YORK (Reuters) - China-based Luckin Coffee Inc's (O:LK) shares could double in price after it overcomes the negative impact of the coronavirus outbreak and a widely publicized bearish bet against its stock, according to Andrew Left, managing partner at hedge fund Citron Capital.

Better known for his short bets, Left, who is also editor of the online investment newsletter Citron Research, has come out in defense of Luckin’s stock, which his fund owns. The stock will probably eventually trade at $60 per share on U.S. exchanges once uncertainty over the coronavirus clears, he told Reuters.

Luckin was forced to temporarily close an estimated 200 coffee shops in Wuhan, capital of the Hubei province in China and epicenter of the deadly virus outbreak.

Its stock slumped as much as 27% on Friday after hedge fund Muddy Waters said it had sold short the shares of the Chinese challenger to Starbucks (O:SBUX), citing an anonymous report that questioned the coffee chain's financials.

Short-sellers aim to profit by selling borrowed shares, hoping to buy them back later at a lower price.

Luckin has denied all allegations in the anonymous report.

Left said he decided to take a position in the stock after conducting an analysis of Luckin's business, including speaking with stakeholders and competitors and reviewing payments data.

"I don't think that report is correct," Left told Reuters.

Luckin shares staged a partial recovery on Friday when Left mounted a defense of its fundamentals via Twitter and said his fund had bought the stock.

Shares were up 14% to $35.64 in afternoon trading on Tuesday.

About 30% of Luckin's available shares have been sold short, with the dollar value of these bearish bets at $951 million, according to financial analytics firm S3 Partners. Left, dubbed "The Bounty Hunter of Wall Street" by New York Times Magazine, is known for successful bets against Valeant Pharmaceuticals (NYSE:BHC) and for publishing critical reports on Chinese companies and profiting when their shares fell.

Carson Block, founder of Muddy Waters, has made his mark in the hedge fund industry by betting against the stocks of a number of Chinese companies that trade on North American stock exchanges after challenging their accounting practices.

Muddy Waters declined to comment.

The shop closures and movement restrictions due to the spreading coronavirus are putting a damper on Luckin's first-quarter results, brokerage Needham said in a note on Tuesday.

Nevertheless, the firm boosted its target price on the company’s shares by 48% to $40, pointing to Luckin's new unmanned retail and tea partnership store initiatives.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.